老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.2288
-0.0491-17.67%
成交量：91.08万
成交额：21.31万
市值：305.77万
市盈率：-0.05
高：0.2769
开：0.2636
低：0.2000
收：0.2779
52周最高：11.00
52周最低：0.0002
股本：1,336.42万
流通股本：340.45万
量比：0.72
换手率：26.75%
股息：- -
股息率：- -
每股收益(TTM):-4.9510
每股收益(LYR):-14.8490
净资产收益率：-1236.83%
总资产收益率：-427.27%
市净率：0.21
市盈率(LYR):-0.02

数据加载中...

总览公司新闻资讯公告
2020/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/03

重要事件披露

8-K - Current report
2020/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/02/11

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/01/17

重要事件披露

8-K - Current report
2019/12/12

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2019/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/10/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/10/08

重要事件披露

8-K - Current report
2019/09/09

重要事件披露

8-K - Current report
更多